Sherwin Sattarzadeh

Chief Operating Officer at Damora Therapeutics · 1 reported transaction in 1 company · latest report Jan 5, 2026

Their trades


Damora TherapeuticsDMRA	Share award — · 190,376 shares	Jan 5, 2026

Jan 5, 2026 · DMRA

190,376

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Operating Officer at Damora Therapeutics · 1 reported transaction in 1 company · latest report Jan 5, 2026


Damora TherapeuticsDMRA	Share award — · 190,376 shares	Jan 5, 2026

Jan 5, 2026 · DMRA

190,376

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.